IL-HILCO-INDUSTRIAL
Hilco Industrial Acquisitions B.V. (www.hilcoind.com ) announced today that it will lead the disposition process for a massive machinery and equipment asset sale which will effectively shut down the automobile manufacturing business on the Australian Continent. The sale comes because of the recent closure of all Toyota Australia manufacturing operations, the last remaining auto production facility remaining on the continent.
This unprecedented auto equipment sale will include all the key production shops and vendors that have been part of the manufacture of cars in Australia for over 60 years. All the equipment will be offered for sale via private treaty from their production shops including aluminum casting, furnaces, engine line machining, assembly, robotic automation, presses, extruders, plastic injection molding machines, welding lines and plant services. Certain key machinery and equipment items will be offered for sale via an online auction including maintenance workshops and general equipment. The auction will be conducted by Grays Online (www.graysonline.com ), a JV partner with Hilco Industrial Acquisitions B.V.
To learn more about this automobile manufacturing equipment sale a special website has been set up: www.australia-automotive.com or at #australiaautomotive.
Offers are invited on all the major equipment and can be made up until October 3, 2017. Negotiations and sales begin immediately. All the equipment offered in this massive sale is available for inspection by appointment only. Please contact: Ernst Rost Onnes (erostonnes@hilcoglobal.com ) immediately to schedule appointments.
Robert Bouland – CEO of Hilco Industrial Acquisitions B.V. said, “There has never been a sale conducted of this magnitude with such an abundance of state of the art manufacturing equipment. While it is unfortunate to see the industry in Australia shut down operations, this sale presents a very significant opportunity for those seeking to acquire critical production equipment to augment their facilities.” Mr. Bouland indicated that the demand globally has been extremely high, especially with the Asia – Pacific region and Europe. He added, “We expect that as we begin to publicize the sale, the North American interest will grow rapidly.”
Sales begin immediately. The equipment offered in the private treaty sale includes all categories of production. All key suppliers and vendors in the sale include the following: Toyota Altona Car Manufacturing Plant; Toyoda Gosei Australia; Continental Pty Ltd.; Britax Childcare; Metalsa Australia; ROH Automotive; Toyota Boshoku Australia; Chassis Brakes International; and Denso Automotive Systems Australia.
To arrange an inspection appointment, access more detailed information about the assets being sold, or learn specific information about the private treaty sale process, please contact: Ernst Rost Onnes toyota@hilcoglobal.com or go to www.australia-automotive.com or #australiaautomotive for more details.
About Hilco Industrial: Hilco Industrial Acquisitions B.V. (www.hilcohia.com ) provides industrial asset acquisition and disposition services, specializing in machinery, equipment and inventory auctions and negotiated sales. It sells the broad range of industrial assets found in manufacturing, wholesale and distribution companies. Hilco Industrial buys and sells assets through on-site, online and combination webcast auction sale events as well as negotiated (private treaty) sales. In addition to providing services on a fee or commission basis, Hilco Industrial puts capital at risk and often acquires assets or provides guarantees. Hilco Industrial is part of Northbrook, Illinois based Hilco Global (www.hilcoglobal.com ), the world’s leading authority on maximizing the value of business assets by delivering valuation, monetization and advisory solutions to an international marketplace. In 2014, Hilco Industrial LLC and CBI (Core Business Industries) formed a joint venture called Hilco Industrial Acquisitions B.V. (Amsterdam) to buy distressed industrial assets, liquidate those which are no longer needed and continue the lucrative operations. Hilco Industrial Acquisitions B.V. is in Europe, Asia and Australia.
About GraysOnline: GraysOnline (www.graysonline.com.au ) is the largest industrial and commercial online auction business in Australasia, offering a huge range of industrial, consumer and commercial goods, direct from manufacturers and distributors. GraysOnline offers buyers great value and convenience and our vendors an efficient sales channel to unlock value from their assets. GraysOnline selling platform and commitment to first-class customer service make buying and selling easy, efficient, fair and transparent. For nearly 100 years, GraysOnline has helped buyers and sellers connect. GraysOnline provides full national coverage across Australia and New Zealand with main offices in Sydney, Melbourne, Adelaide, Brisbane, Darwin, Perth, Auckland and Christchurch, covering approximately 60,000 sqm of warehouse space, 120,000 sqm of yard space and over 38 additional smaller sites and regional depots. Through our international network, we can access networks of buyers and sellers in Asia, the Middle East, Africa and Europe.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170621005110/en/
Contact:
Hilco Global
Gary C. Epstein
EVP – Chief Marketing Officer
gepstein@hilcoglobal.com
www.hilcoglobal.com
+1
847 418 2712
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 Data for Incyte’s Retifanlimab (Zynyz®) in Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) Published in The Lancet13.6.2025 00:45:00 CEST | Press release
POD1UM-303/InterAACT 2 is the first and largest global Phase 3 trial evaluating a PD-1 inhibitor in combination with chemotherapy for the treatment of patients with advanced SCAC not previously treated with systemic chemotherapy The trial met its primary endpoint; treatment with retifanlimab in combination with platinum-based chemotherapy (carboplatin-paclitaxel) resulted in clinically meaningful improvements in progression-free survival and overall survival In May 2025, the U.S. Food and Drug Administration (FDA) approved Zynyz® (retifanlimab-dlwr) in combination with carboplatin and paclitaxel and as a single agent for the treatment of advanced SCAC; submissions to other global regulatory agencies are also under review Incyte (Nasdaq:INCY) today announced that primary results from the Phase 3 POD1UM-303/InterAACT 2 trial of retifanlimab (Zynyz®), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with carboplatin and paclitaxel (platinum-base
Güntner Drives Group-Wide Innovation in 2024 Sustainability Report12.6.2025 21:30:00 CEST | Press release
Progress in natural refrigerants, water efficiency and circular economy underscores Güntner’s global impact Güntner, a global leader in refrigeration and heat exchange technology, today announced its featured role in the newly released 2024 A-HEAT Sustainability Report. The report outlines significant progress toward ambitious environmental goals—fueled by Güntner’s commitment to measurable, innovation-led sustainability. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612897493/en/ Güntner advances global sustainability goals with progress in natural refrigerants, water savings, and circular economy efforts. Working toward its 2030 sustainability targets, Güntner delivered significant achievements across key areas including natural refrigeration integration, water and energy efficiency and the development of circular economy solutions. These efforts reflect Güntner’s ongoing mission to make sustainability not just a goal,
Windsurf Launches First GPU Cluster in Germany, Expanding Secure Enterprise AI in Europe12.6.2025 20:45:00 CEST | Press release
Windsurf launches a GPU cluster in Germany, delivering 50% faster performance and secure access to European enterprises. Data residency ensures enterprise repositories stay within the EU, meeting stringent security requirements. Windsurf already supports 100+ European enterprise customers, highlighting strong demand for AI-powered development tools across EMEA. Windsurf, a leader in AI-powered software development, today announced its first GPU cluster in Germany, as product demand surges and the company expands performance capacity across the EU. With over 100 local enterprise customers already using Windsurf products, the new cluster marks the company’s first major international step in building scalable infrastructure for the European market. Located in Frankfurt, home to some of the world’s strictest data security laws, the cluster was a natural choice for Windsurf’s first deployment. This cluster was specifically designed to meet the unique security and performance requirements of
Xsolla Partners With Defold to Enable Seamless In-game Purchases for Web Developers12.6.2025 19:00:00 CEST | Press release
New SDK Integration Simplifies Monetization for Defold Developers Publishing on CrazyGames Ahead of Global Game Jam Xsolla, a leading global video game commerce company, announces a new strategic partnership with Defold, the cross-platform game engine trusted by professionals and indie developers worldwide. This collaboration introduces a seamless integration between Xsolla and Defold-built web games on CrazyGames, enabling developers to easily monetize their titles just in time for the CrazyGames x Defold Game Jam running June 13–15. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612569206/en/ (Graphic: Xsolla) To address the complexity of in-game monetization, Xsolla and Defold have developed a new SDK that allows Defold developers to implement in-game purchasing functionality without the complex manual API setup required. With Xsolla’s sponsorship and support, this integration removes friction from the monetization jou
Pioneering Cancer Plasticity Atlas will Help Predict Response to Cancer Therapies12.6.2025 17:00:00 CEST | Press release
The Wellcome Sanger Institute, Parse Biosciences, and the Computational Health Center at Helmholtz Munich today announced a collaboration to build the foundation of a single cell atlas, focused on understanding and elucidating cancer plasticity in response to therapies. The collaboration will catalyze an ambitious future phase to develop a cancer plasticity atlas encompassing hundreds of millions of cells. Utilizing novel organoid perturbation and Artificial Intelligence (AI) platforms, the aim is to create a comprehensive dataset to fuel foundational drug discovery models and cancer research. Dr. Mathew Garnett, Group Leader at the Sanger Institute, and Prof. Fabian Theis, Director of the Computational Health Center at Helmholtz Munich and Associate Faculty at the Sanger Institute, will be the principal investigators in the collaboration. Garnett’s research team has generated novel 3D organoid cultures that serve as highly scalable and functional cancer models with the ability to capt
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom